secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2023-03-21T23:59:59+00:00
Accession:  0001628280-23-008639
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead shareholders elect eight directors, approve executive compensation and share increase
--------------------------------------------------------------------------------

- All eight director nominees elected; votes ranged from ~62.8M to ~67.8M in favor.
- Advisory vote on executive compensation passed with 62,683,718 for, 7,119,440 against.
- Amendment to increase authorized common shares approved: 80,352,213 for, 8,279,373 against.
- Ratification of Rose Snyder & Jacobs as auditors passed: 86,613,251 for, 1,296,520 against.
- Broker non-votes of ~18.7M were recorded on director election and executive compensation proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828023008639/0001628280-23-008639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828023008639/arwr-20230316.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-008639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer